Safeguard Scientifics Announces Agenda for Investor Day 2014

Share Article

RSVP and Request One-on-One Meetings at

News Image
Investor Day 2014 will offer the investor community an opportunity to hear from Safeguard’s executive team along with executives from Safeguard’s partner companies about growth opportunities and value creation strategies.

Safeguard Scientifics, Inc. (NYSE:SFE) will be hosting its 8th Annual Investor Day at the New York Stock Exchange on Wednesday, October 15, 2014 from 8:00am–12:00pm EDT.

Investor Day 2014 will offer the investor community an opportunity to hear from Safeguard’s executive team along with executives from Safeguard’s partner companies about growth opportunities and value creation strategies.


8:00 a.m.
Registration and Breakfast

8:30 a.m.    
Opening Remarks

  • John E. Shave III – SVP, Investor Relations and Corporate Communications, Safeguard Scientifics

8:35 a.m.    
Safeguard Scientifics

  • Stephen T. Zarrilli – President and CEO, Safeguard Scientifics
  • Jeffrey B. McGroarty – SVP and CFO, Safeguard Scientifics

9:05 a.m.    
Good Start Genetics

  • Don Hardison, CEO, Good Start Genetics

9:35 a.m.    

  • Ben Kartzman, Co-Founder and CEO, Spongecell

10:05 a.m.

10:15 a.m.

  • Jean Hoffman, Founder, President and CEO, Putney

10:45 a.m.

  • Sundeep Bhan, Co-Founder and CEO, Medivo

11:15 a.m.

  • Joe Zawadski, Co-Founder and CEO, MediaMath

11:45 a.m.
Closing Remarks followed by Luncheon with Informal Conversation

Please note that presenting partner companies and agenda are subject to change.

RSVP and ONE-ON-ONES: Interested in meeting with members of Safeguard’s executive team and/or Safeguard’s partner company CEOs? Please RSVP for Safeguard’s Investor Day 2014 and submit your one-on-one requests at by Friday, October 10th.

Questions? Please contact us at (610) 975-4944 or IR(at)safeguard(dot)com.

About Safeguard Scientifics

Safeguard Scientifics, Inc. (NYSE:SFE) has a distinguished track record of fostering innovation and building market leaders. For six decades, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on two sectors—healthcare and technology. Recent successful exits include Alverix (acquired by Becton, Dickinson for $40 million); Crescendo Bioscience (acquired by Myriad Genetics for $270 million); NuPathe (acquired by Teva Pharmaceutical Industries for $144 million); and ThingWorx (acquired by PTC for initial proceeds of $112 million). For more information, please visit or Follow Us on Twitter @safeguard.

Forward-looking Statements

Except for the historical information and discussions contained herein, statements contained in this release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, our substantial capital requirements and absence of liquidity from our partner company holdings, fluctuations in the market prices of our publicly traded partner company holdings, competition, our inability to obtain maximum value for our partner company holdings, our ability to attract and retain qualified employees, market valuations in sectors in which our partner companies operate, our inability to control our partner companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our partner companies, including the fact that most of our partner companies have a limited history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard’s partner companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond the Company’s ability to predict or control. As a result of these and other factors, the Company’s past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John E. Shave III
since: 01/2010
Follow >
Safeguard Scientifics
Like >
Safeguard Scientifics

Follow us on
Visit website